Skip to main content

Analysts Offer Insights on Technology Companies: Salesforce (CRM) and BOE Varitronix (OtherVARXF)

Tipranks - Sat Feb 28, 5:57AM CST

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Salesforce (CRMResearch Report) and BOE Varitronix (VARXFResearch Report) with bullish sentiments.

Claim 50% Off TipRanks Premium

Salesforce (CRM)

In a report released today, Saiyi He from CMB International Securities maintained a Buy rating on Salesforce, with a price target of $320.00. The company’s shares closed last Thursday at $199.47.

According to TipRanks.com, He is a 4-star analyst with an average return of 9.6% and a 51.1% success rate. He covers the NA sector, focusing on stocks such as Alphabet Class C, Meta Platforms, and NetEase. ;'>

Salesforce has an analyst consensus of Moderate Buy, with a price target consensus of $276.17, which is a 40.4% upside from current levels. In a report issued on February 13, TipRanks – PerPlexity also upgraded the stock to Buy with a $215.00 price target.

See the top stocks recommended by analysts >>

BOE Varitronix (VARXF)

In a report released today, Alex NG from CMB International Securities maintained a Buy rating on BOE Varitronix, with a price target of HK$8.40. The company’s shares closed last Thursday at $0.67.

NG has an average return of 6.1% when recommending BOE Varitronix. ;'>

According to TipRanks.com, NG is ranked #355 out of 12136 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for BOE Varitronix with a $1.07 average price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.